Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
ATP binding cassette subfamily C member 6 | 0.540 | 0.654 | 5.6E-35 |
|
disease | 0.010 | None | 1.000 | 1 | 2 | 2017 | 2017 | ||||||||
|
ATP binding cassette subfamily F member 1 | 0.674 | 0.538 | 1.3E-09 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
acetylcholinesterase (Cartwright blood group) | 0.445 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 18 | 0 | 1995 | 2020 | ||||||||
|
adenylate cyclase activating polypeptide 1 | 0.510 | 0.846 | 0.52 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
adrenoceptor beta 2 | 0.442 | 0.923 | 0.53 |
|
disease | 0.020 | None | 0.500 | 2 | 0 | 2004 | 2017 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
activator of HSP90 ATPase activity 1 | 0.396 | 0.923 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
aminoacyl tRNA synthetase complex interacting multifunctional protein 2 | 0.393 | 0.923 | 8.0E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
autoimmune regulator | 0.516 | 0.808 | 4.0E-12 |
|
disease | 0.080 | None | 0.875 | 8 | 1 | 2008 | 2019 | ||||||||
|
albumin | 0.317 | 0.962 | 0.64 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2010 | 2010 | ||||||||
|
adenine phosphoribosyltransferase | 0.423 | 0.846 | 5.5E-13 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
aquaporin 4 | 0.456 | 0.885 | 2.3E-03 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2010 | 2018 | ||||||||
|
atrophin 1 | 0.409 | 0.885 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
ATPase H+ transporting V1 subunit G2 | 0.839 | 0.269 | 2.9E-03 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
beta-1,3-glucuronyltransferase 1 | 0.494 | 0.769 | 0.14 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
butyrylcholinesterase | 0.447 | 0.923 | 1.1E-13 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 2011 | 2020 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
BMP/retinoic acid inducible neural specific 1 | 0.615 | 0.615 | 0.99 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
butyrophilin like 2 | 0.546 | 0.808 | 8.6E-11 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||||||
|
complement C2 | 0.617 | 0.692 | 1.3E-16 |
|
disease | 0.110 | None | 1.000 | 2 | 1 | 2012 | 2013 | ||||||||
|
chromosome 20 open reading frame 181 | 0.479 | 0.885 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | |||||||||
|
complement C4A (Rodgers blood group) | 0.563 | 0.769 | 1.5E-11 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1992 | 1992 |